Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Phase of Trial: Phase III
Latest Information Update: 09 Dec 2017
At a glance
- Drugs Atezolizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colon cancer
- Focus Therapeutic Use
- Acronyms ATOMIC
- 14 Sep 2017 Status changed from not yet recruiting to recruiting.
- 04 Aug 2017 Planned number of patients changed from 720 to 700.
- 06 Jun 2017 According to trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology, two interim analyses are planned at 50% and 75% of events.